Expansion Opportunity Genentech is expanding manufacturing capacity on the East Coast with a new Holly Springs plant, signaling growing production needs, supply chain optimization, and potential demand for manufacturing, facility automation, and industrial services.

Alzheimer's Portfolio Genentech plans to present new data at AAIC 2026, indicating active R&D in neurodegenerative therapies and potential opportunities for clinical research support, data management, and biomarker analytics collaborations.

Strategic Partnerships Recent collaboration with Ark BioSciences and ongoing ties with Roche and other biotechs suggest opportunities for joint research platforms, data integration, and cross-company cloud or analytics solutions.

Restructuring Signals Reported headcount reductions alongside ongoing programs imply potential needs in change management, IT workforce augmentation, and scalable automation or outsourcing services to maintain productivity.

Ally in Oncology Active development in breast cancer therapy and partnerships with Astex Pharmaceuticals point to opportunities in drug discovery tooling, HCP-facing analytics, and commercialization readiness solutions for oncology portfolios.